Skip to main content

Our Purpose

Our Purpose is to improve the lives of people with glaucoma and those at risk, by increasing early detection and positive treatment outcomes through education, advocacy, and research. We empower individuals to understand and take an active interest in their own eye health; we promote research, innovation and work collaboratively with health care professionals. 


Our Mission

To prevent glaucoma blindness by increasing early detection and improving patient treatment outcomes. 


Our Vision

An Australia free from glaucoma blindness. 


Our Strategic Priorities

  • Awareness and Detection - Raising the awareness of glaucoma in the community & enacting programs that enable early detection.
  • Education and Support - Be the authoritative source of glaucoma education in Australia & support patients throughout their glaucoma treatment journey.
  • Extension of Care - Support healthcare professionals by extending their care beyond patient consultations by emphasising key treatment messages, encouraging adherence to medications and follow up appointments and helping to reduce patient anxiety and uncertainty.
  • Research - Support Australian based researchers as they seek to improve glaucoma detection, improve treatment outcomes and search for the treatments of tomorrow.
  • Advocacy - Provide a powerful voice to Government on issues that affect glaucoma patients.

Our Values

  • Leadership - We support & advocate for people with glaucoma.
  • Empowerment - We give people with glaucoma confidence in their eye care.
  • Respect - We encourage and respect our staff, volunteers and all partners and find innovative and collaborative ways to benefit their overall wellbeing.
  • Expertise - We drive and champion evidence-based research, education, and professional collaboration.
  • Integrity - We provide a consistent, informed, empathic approach with the broader community, patients, and professionals.
Our Strategy
Strategic Plan on a Page
Annual Reports
Annual Report 2022/23
Annual Report 2021/22
Impact Report 2023
Board Members
Committees

 

Clinical Advisory Panel
Show less
Show more

Dr Katherine Masselos - Chair, Ophthalmologist
Dr David Wechsler - Ophthalmologist
Dr Nelson Kuo - Ophthalmologist
Dr Mark Chiang - Ophthalmologist
Dr Jennifer Fan-Gaskin  - Ophthalmologist
Dr Brian Ang - Ophthalmologist
Dr Geoffrey Chan - Ophthalmologist

Dr Ben Ashby - Optometrist 
Inez Hsing - Optometrist
Ho Wah Ng  - Optometrist
Anna Delmadoros - Optometrist
Janelle Tong – Optometrist
Sarah Guillemain – Optometrist

Khanh Nguyen - Pharmacist
Han Fey Yap - Pharmacist
Jessica Leung - Pharmacist
Mariyam Aly - Pharmacist
Nhan Do - Pharmacist

Media & Digital Technology Committee
Show less
Show more

Satish Chandar - Chair
Dr Ben Ashby
Maree O’Brien

Finance & Audit Committee
Show less
Show more

William Peter Day - Chair
Lynette Klein
Tim Conroy

Sustainability & Risk Committee
Show less
Show more

Lynette Klein - Chair
Maree O’Brien
Dr Ben Ashby
Satish Chandar
William Peter Day
Kay Richards

Independent Research Panel
Ambassadors
Kirk Pengilly
Our Supporters

It is only through the support and generosity of notable individuals, corporate sponsors, trusts and foundations that Glaucoma Australia can continue to accomplish its vision.

Our Research

Since its inception, Glaucoma Australia has committed over $1 million to support Australian glaucoma research across a diverse range of projects.

Honorary Life Governors
Contact Us

Glaucoma Australia provides free education and support to people living with glaucoma.